MedTrace Logo

Menopausal Symptoms and Burnout: Comparison of Occupational Health Issue Among Health Professionals in UMC Hospitals

NCT04728126 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2021-01-29

No results posted yet for this study

Summary

This study aims at evaluating the burnout in women healthcare providers (physicians and nurses) Kazakhstan settings, and to investigate the potential parameters that play a role in increasing the risk of burnout. This study would apply the Oldenburg Burnout Inventory (OBI) in a sample of menopausal healthcare providers belonging to the University Medical Center (UMC) - quaternary healthcare institution in Nur-Sultan, Kazakhstan.

Conditions

Interventions

OTHER

Survey

The questionnaire will include socio-demographic information (i.e., gender, age, job seniority) and sub-scales for measuring study variables (i.e., menopausal symptoms, social and personal resources, burnout, and work ability). Menopausal symptoms will be assessed using the Menopause-Specific Quality of Life questionnaire. Job burnout will be measured through OBI inventory, which consists of 16 items describing the states of emotional exhaustion and detachment - two core dimension of burnout, and were developed to meet different occupational groups. The menopause and the quality of working environment will be assessed using the Questionnaire developed by National Health Service in England and Wales.

Sponsors & Collaborators

  • University of South Florida

    collaborator OTHER

  • Università degli Studi dell'Insubria

    collaborator OTHER

  • Nazarbayev University Medical Center

    lead OTHER

Principal Investigators

  • Milan Terzic · Nazarbayev University Medical Center

  • Gauri Bapayeva · Nazarbayev University Medical Center

Eligibility

Min Age
45 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2023-02-28
Completion
2024-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04728126 on ClinicalTrials.gov